Overexpression of OPN in several cancers such as breast cancer, malignant haematological diseases or oral squamous cell carcinoma (OSCC) [11,12] predicts poor overall survival, suggesting its role as a prognostic biomarker [10]. This evidence concerns the gene SPP1 and hematologic disorder.